Welcome to episode 056 of Life Sciences 360.

Welcome to another episode of Life Sciences 360! In this episode, Harsh Thakkar is joined by Joel Eichmann, co-founder and managing director of Green Elephant Biotech. Green Elephant Biotech is a trailblazer in the biotech industry, focusing on sustainability and using plant-based materials to create innovative products. Joel shares the fascinating journey of how Green Elephant Biotech started, the challenges they faced, and the future of sustainable biotech.

Chapters:

00:00 - Introduction
01:23 - Welcoming Joel Eichmann
02:39 - Origins of Green Elephant Biotech
05:15 - From Concept to Commercial Product
07:30 - Early Challenges and Strategies
10:02 - Advice for Aspiring Biotech Entrepreneurs
12:33 - Incorporating Sustainability
15:01 - Hiring and Building the Team
18:37 - Understanding the Life Sciences Industry
21:19 - Balancing Innovation and Sustainability
24:05 - Industry Challenges and Opportunities
27:34 - Generating New Product Ideas
30:13 - Recognition and Awards
31:31 - Long-term Goals and Automation
34:28 - The Future of Automation in Biotech
36:06 - Where to Learn More About Green Elephant Biotech
37:44 - Final Thoughts on Sustainability


Connect with Joel Eichmann -

Green Elephant Biotech: (https://www.greenelephantbiotech.com/)
Joel Eichmann: (https://www.linkedin.com/in/joel-eichmann/)
Harsh Thakkar: (https://www.linkedin.com/in/harshvthakkar/)

*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#LifeSciences360 #GreenElephantBiotech #Sustainability #BiotechInnovation #HarshThakkar #JoelEichmann #PlantBasedMaterials #Bioprocessing #Automation

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 055 of Life Sciences 360.

In this episode of Life Sciences 360! In this episode, Harsh sits down with Dr. Kate Broderick, Chief Innovation Officer at Maravai Life Sciences. Dr. Broderick shares her journey from academia to leading innovation in the biotech industry, discusses the pivotal role of Clean Cap technology in COVID-19 vaccines, and explores the future applications of mRNA. Learn about the collaborative spirit at Maravai and the exciting developments in genomic medicine, personalized cancer vaccines, and more.

Join Harsh Thakkar in an insightful conversation with Dr. Kate Broderick, the Chief Innovation Officer at Maravai Life Sciences. Discover the future of mRNA, the role of Clean Cap technology in COVID-19 vaccines, and the innovative work happening at Maravai and its subsidiaries.


Chapters:

00:00 - Introduction
00:03 - Dr. Kate Broderick's Career Background
00:38 - Overview of Maravai Life Sciences
01:22 - Starting in Life Sciences and Career Journey
03:17 - Role of Chief Innovation Officer
04:02 - Turning Ideas into Innovations
05:22 - Blending Research, Development, and Leadership
07:40 - Working at Maravai and Cross-functional Leadership
08:05 - Clean Cap Technology and its Impact
09:15 - Maravai’s Business Units and Synergies
10:25 - Clean Cap in COVID Vaccines
11:48 - Future Applications of mRNA
13:31 - Overcoming Challenges with mRNA
15:09 - Improving Stability and Targeting Specific Cells
17:49 - Importance of Collaboration in Science
19:25 - Maravai's Approach to Partnerships and Collaborations
23:12 - New mRNA Manufacturing Facility
25:22 - Functional Segmentation of Facilities
27:35 - Recognition as a Top Biotech Executive
29:46 - Exciting Areas in Life Sciences for the Future
31:50 - Potential of CRISPR and Base Editing
33:19 - Closing Remarks and Contact Information


Connect with Dr. Kate Broderick:
- Kate Broderick (https://www.linkedin.com/in/katebroderick)
- Maravai Life Sciences: (https://www.maravai.com)
- TriLink Biotechnologies: (https://www.trilinkbiotech.com)

Stay Tuned for More Episodes:
Subscribe to Life Sciences 360 for more interviews and insights from leaders in the biotech and life sciences industry.

---

#Biotech #LifeSciences #ResearchAndDevelopment #BiotechIndustry #FutureOfMedicine #ScienceAndTech

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 054 of Life Sciences 360.

In this episode of Life Science 360 ,Today, we are thrilled to have Lisa Sellers, the CEO of Vector Labs, as our special guest. Lisa shares her incredible journey from working at big names like Thermo Fisher and 10x Genomics to leading Vector Labs, a trusted manufacturer of reagents and critical components in the life sciences sector.

In this episode, we dive deep into:
- Lisa's transition from being an industry professional to becoming a CEO
- The unique challenges and benefits of working in smaller companies
- Vector Labs' strategic acquisitions and mergers to expand their product portfolio
- The impact of Vector Labs in the pharmaceutical, diagnostic, and academic sectors
- Lisa's passion for mentorship and her efforts to inspire the next generation in STEM fields

Chapters :

00:00 - Introduction
00:41 - Welcome Lisa Sellers
01:12 - Lisa’s Career Journey
02:37 - Transition to CEO
05:00 - Comparing Big Companies to Smaller Companies
09:28 - Vector Labs’ Product and Service Overview
14:25 - Recent Acquisitions and Expansions
17:20 - Role of Private Equity in Vector Labs
20:28 - Challenges in Protein and Glycan Detection
23:54 - Vector Labs’ Diverse Customer Base
26:59 - Managing Priorities and Resources
29:00 - Vision for Vector Labs in the Next 5 Years
32:39 - Lisa’s Mentorship and Community Involvement
37:17 - Key Leadership Qualities in STEM
41:28 - Final Thoughts and Closing

Stay tuned and don't forget to subscribe for more in-depth conversations with leading scientists and innovators in the life sciences field!

-----

Links:

*Lisa Sellers: (https://www.linkedin.com/in/lisa-sellers/)
*Vector Labs: (https://www.linkedin.com/company/vector-laboratories/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#LifeSciences360 #VectorLabs #LisaSellers #Biotech #Pharmaceuticals #ScienceLeadership #STEMMentorship #CareerJourney #LifeSciences #IndustryLeadership #Bioconjugation #ProteinDetection #CompanyGrowth #InnovationInScience #LeadershipInBiotech #WomenInSTEM

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 053 of Life Sciences 360.

In this episode of Life Science 360, our host Harsh Thakkar sits down with Brian Cosgrove, Principal Scientist at Tune Therapeutics. Brian dives deep into the fascinating world of epigenetics and its role in developing therapies for complex diseases. He shares insights on how Tune Therapeutics is leveraging the power of the epigenome to create innovative treatments, particularly focusing on their work with hepatitis B and the promising potential of their tempo platform.

Chapters:

00:00 - Introduction
00:02 - Understanding Cell Differentiation and Gene Regulation
00:37 - Welcome Brian Cosgrove from Tune Therapeutics
01:15 - Brian's Transition from Duke University to Tune Therapeutics
02:03 - The Basics of Epigenetic Tuning
02:38 - How Epigenetics Determines Cell Function
03:55 - The Role of the Epigenome in Gene Expression
05:06 - The Complexity of the Human Body and Scientific Research
06:12 - Deep Dive into Hepatitis B (HBV)
06:57 - Current Treatments for Chronic Hepatitis B
08:32 - The Unmet Need in Hepatitis B Treatment
09:09 - Brian's Career Path and Decision to Join Tune Therapeutics
12:03 - Growth and Evolution of Tune Therapeutics
15:25 - Challenges and Rewards of Joining an Early-Stage Company
17:49 - Introduction to the Tempo Platform
19:04 - How Tempo Platform Works with HBV
20:32 - Epigenetic Regulation of HBV
23:20 - Future Applications of Epigenetic Tuning
24:38 - Timeline for Tune 401 Clinical Trials
26:08 - Anticipated Challenges and Solutions
27:20 - Partnering for Manufacturing and Delivery
28:32 - The Broader Field of Epigenetic Therapies
30:21 - Potential Global Impact of Epigenetic Therapies
32:12 - The Most Rewarding Part of Brian's Work
33:01 - The Personal Side of Working in Life Sciences
35:10 - Final Thoughts and Future Outlook for Tune Therapeutics
36:09 - Closing Remarks and How to Connect with Brian

Stay tuned and don't forget to subscribe for more in-depth conversations with leading scientists and innovators in the life sciences field!

-----
Links:

*Brian Cosgrove LinkedIn (https://www.linkedin.com/in/brian-cosgrove-171b926/)
*Tune Therapeutics LinkedIn (https://www.linkedin.com/company/tunetx/ )
*Tune Therapeutics website (https://tunetx.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#LifeScience360 #Epigenetics #GeneRegulation #TuneTherapeutics #Biotech #HepatitisB #MedicalResearch #GeneTherapy #BrianCosgrove #ScientificInnovation #HealthTech #CRISPR #Epigenome #Genomics #Bioengineering #FutureOfMedicine #LifeSciences #TherapeuticResearch #BiomedicalScience

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 052 of Life Sciences 360.

In this episode, of Life Sciences as we dive into the fascinating world of psychedelic therapeutics with Dr. Sam Clark, the Chief Executive Officer of Terran Biosciences. Dr. Clark shares his journey of founding Terran Biosciences, motivated by the need for better treatment options for psychiatric and neurological disorders. Discover how Terran Biosciences is leveraging a tech company structure to accelerate drug development, utilizing AI in imaging, and pioneering innovative prodrugs.

Learn about the company’s groundbreaking work in developing psychedelics without hallucinations and their mission to make these therapies affordable and accessible to patients.

Subscribe for more insightful conversations with leaders in the biotech and life sciences industries!

Chapters:

00:00 - Introduction
00:12 - Dr. Sam Clark's Motivation and Background
01:00 - Founding Terran Biosciences
01:35 - Challenges in Psychiatric and Neurological Treatment Development
02:55 - Innovating with a Tech Company Structure
03:18 - Use of AI and Drug Development Strategies
04:18 - Slow Translation of Research to Therapies
05:50 - Development of New Prodrugs
07:12 - Explanation of Prodrugs
08:49 - Terran's Lead Assets for Psychotic Disorders
10:16 - Creating Long-Acting Prodrugs
12:16 - Addressing Regulatory Hurdles in Psychedelic Research
14:20 - Pipeline Overview and Future Plans
16:13 - Importance of Collaboration in Psychedelic Research
17:58 - The Rise of Big Pharma Interest in Neuroscience
20:14 - Addressing Stigma Around Psychedelics
23:02 - Overcoming Regulatory Challenges
26:31 - Trends in Psychedelic Funding
31:48 - Making Medications More Accessible
37:00 - Impact of Psychedelic Approvals on the Industry
38:20 - Focus on Patient-Centric Approaches
41:11 - Final Thoughts and Future Announcements

Follow Terran Biosciences on LinkedIn and X, and visit their website for the latest updates and announcements.

-----

Links:

- [Terran Biosciences on LinkedIn](https://www.linkedin.com/company/terran/)
- [Terran Biosciences on X](https://x.com/terranbio)
- [Dr. Sam Clark on X](https://x.com/neonneurons)
- [Terran Biosciences Website](https://terranbio.com)
- [Tera XT Website](https://teraxt.com)

For more, check out the podcast website - www.lifesciencespod.com

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 050 of Life Sciences 360.

In this episode, Harsh Thakkar chats with Tony Martignetti, a top leadership development voice on LinkedIn and an advisor to numerous tech and life sciences executives. Tony shares his insights on inspired leadership, the importance of investing in people, and how to unlock potential within teams. They also discuss the concept of flashpoints in both personal and organizational contexts and the value of embracing divergent thinking in the workplace.

Chapters:
00:00 Introduction to Tony Martignetti and Leadership Development
01:04 Advocating for Inspired Leadership
02:23 Influences: Henry Tamir and “No Rules, Rules” Book
04:37 Investing in People: Beyond Pedigree
06:19 Authentic Leadership: Bringing Your Whole Self to Work
09:40 The Core Model: Encouraging Authenticity in Teams
11:33 Identifying and Aligning Personal and Organizational Flashpoints
13:04 Overcoming Barriers: Personal Stories and Career Challenges
16:13 Flashpoints in Organizations: Examples and Insights
19:34 Embracing Divergent Thinking for Innovation
25:30 Convergent Hearts: Building Connection and Understanding
30:46 Practical Tips for Leaders to Foster Innovation and Growth
35:21 Specialist vs. Generalist: Expanding Skills and Knowledge
39:36 Key Takeaways: Expanding Vision and Narrowing Focus

-----
Links:

*Tony Martignetti LinkedIn (https://www.linkedin.com/in/tonymartignetti1/)
*Tony Martignetti Website (https://ipurposepartners.com/)
*Harsh Thakkar LinkedIn (https://www.linkedin.com/in/harshvthakkar/)
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 049 of Life Sciences 360.

In this episode of Life Sciences 360, host Harsh Thakkar welcomes Jesse Mendelsohn, Senior Vice President at Model N. Jesse delves into the intricacies of revenue optimization and compliance within the pharmaceutical industry. He shares insights on how Model N's platform aids pharmaceutical companies in navigating complex pricing, regulatory challenges, and government negotiations.

Chapters :
0:00 - Introduction
1:30 - Welcoming Jesse Mendelsohn
2:00 - Jesse's Journey with Model N
6:00 - Evolution of Pharma Pricing and Compliance
8:30 - Challenges in Commercial Contracting
12:00 - Regulatory Side of Pharma Pricing
14:30 - Impact of Government as a Major Drug Purchaser
16:00 - Inflation Reduction Act Overview
19:00 - Medicare's Right to Negotiate Drug Prices
21:00 - Aftershocks of the Inflation Reduction Act
23:30 - Key Takeaways for Pharma Executives
26:00 - Impact on Drug Development Strategy
28:00 - Generics and Biosimilars Market Impact
30:30 - Positive Outcomes of the Inflation Reduction Act
32:00 - What's Next for Model N
36:00 - Importance of Accurate Data in Pricing
38:30 - Closing Remarks and Connect with Jesse
-----
Links:

* Jesse Mendelsohn LinkedIn (https://www.linkedin.com/in/jessedm/)
* Model N LinkedIn (https://www.linkedin.com/company/modeln/)
* Model N website (https://www.modeln.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.

For more, check out the podcast website - www.lifesciencespod.com